Gunderson Dettmer Advises Contineum Therapeutics In Its Initial Public
Gunderson Dettmer Advises Contineum Therapeutics in its Initial Public ...
Gunderson Dettmer Advises TScan Therapeutics on Initial Public Offering ...
Gunderson Dettmer Advises Viking Global in its Investment in Abdera’s ...
Gunderson Dettmer Advises ARCH Venture Partners in its Leadership of ...
Gunderson Dettmer Advises Avoro Ventures in its Participation in Hemab ...
Gunderson Dettmer Advises Thrive AI Health in its Launch | Gunderson ...
Gunderson Dettmer Advised Kelonia Therapeutics in its $800 million ...
Gunderson Dettmer Advised Kelonia Therapeutics in its $800 million ...
Gunderson Dettmer Advises Tarsus Pharmaceuticals in its Upsized ...
Gunderson Dettmer Advises Tarsus Pharmaceuticals in its $200M Committed ...
Advertisement Space (300x250)
Gunderson Dettmer Advises Spark Capital in its Early-Stage Fund and a ...
Gunderson Dettmer Advises ESG Solutions, Novata in its $30M Series B ...
Gunderson Dettmer Advises Lightmatter in its $154M Series C financing ...
Gunderson Dettmer Advises Mexico-Based OCN in its $86M Series A ...
Gunderson Dettmer Advises Mexico-Based OCN in its $86M Series A ...
Gunderson Dettmer Advises Viking Global in its Investment in Abdera’s ...
Gunderson Dettmer Advises Trustwise in its Official Launch and $4M Seed ...
Gunderson Dettmer Advises Wing in its $600M fund formation | Gunderson ...
Gunderson Dettmer Advises HC9 Ventures in its $83 million new fund ...
Gunderson Dettmer Advises Liminal in its $5M Seed Financing | Gunderson ...
Advertisement Space (336x280)
Gunderson Dettmer Advises NextView Ventures in its $200M New Investment ...
Gunderson Dettmer Advises PredictionStrike in its $10M Series A Led by ...
Gunderson Dettmer Advises Better Stack in its $18.6 million Series A ...
Contineum Therapeutics Announces Pricing of Initial Public Offering ...
Gunderson Dettmer Represented Long-Time Client BillionToOne in its $273 ...
Gunderson Dettmer Advises OrbiMed in closing more than $4.3 Billion in ...
Gunderson Dettmer Represents Further Ventures in its $5M Investment ...
Gunderson Dettmer Advises Zendrive in Acquisition of Technology by ...
Gunderson Dettmer Advises Health Velocity Capital in the formation of ...
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Chronic ...
Advertisement Space (336x280)
Gunderson Dettmer Advises Tarsus Pharmaceuticals On $115.0 Million ...
Gunderson Dettmer Represents Stainless in Acquisition by Anthropic ...
Contineum Therapeutics Initiates Patient Dosing in P-Ib Study to ...
Gunderson Dettmer Represents The Column Group in Surrozen’s $175 ...
Gunderson Dettmer Hosts the Webinar: The Latest in GenAI: Updates on ...
Gunderson Dettmer Advises Coupa Software Incorporated on Rule 144A ...